Sera Prognostics (SERA) Preferred Shares Issued (2020 - 2021)

Sera Prognostics (SERA) reported Preferred Shares Issued of -$75000.0 for Q3 2021, down 100.19% quarter-over-quarter from $38.6 million in Q2 2021.

Sera Prognostics (SERA) Preferred Shares Issued (2020 - 2021) Analysis & Trends

Sera Prognostics has reported Preferred Shares Issued for 2 years, with the latest figure at -$75000.0 in Q3 2021.

For the quarter ending Q3 2021, Preferred Shares Issued changed N/A year-over-year to -$75000.0; the trailing twelve-month figure through Jun 2022 stood at -$75000.0 (down 100.03% YoY), and the FY2021 full-year result was $99.0 million, down 23.24% from the prior year.
Preferred Shares Issued for Q3 2021 stood at -$75000.0, down from $38.6 million in the prior quarter.
The five-year high for Preferred Shares Issued was $129.0 million in Q4 2020, with the low at -$75000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Sera Prognostics	93.48 Mn	93.48 Mn	-28,000.00	-

Download Data